The single nucleotide variant at c.662A>G in human RRM2B is a loss-of-function mutation.

In conclusion, the functional assay in this study provided the direct evidence proving that the N221S variation is a loss-of-function mutation and plausibly related to the pathogenic developmental defects found in the infants of previous clinical reports.